BioSpace News Archive

Alphyn Biologics announced today positive results from the first cohort of its Phase 2a clinical trial of AB-101a, a topical therapeutic for mild-to-moderate atopic dermatitis (AD).

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the United States Patent and Trademark Office has granted the Company a patent titled “Methods and Compositions for Treating Diabetes.”

Element Biosciences, Inc. announced that Element CEO and Co-Founder Molly He will speak at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:30 p.m. Pacific Time at the Westin St. Francis hotel in San Francisco.

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics.

Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO, reiterates its commitment to advancing clinical research through Technology and Data Integrity by increasing its clinical operations in the US.

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 11th at 3:00 p.m. PT.

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company today announced that the Company will participate in the J.P. Morgan 41st Annual Healthcare Conference on Monday, January 9, 2023 at 1:30 p.m. PT.

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced the appointment of Raymond Jordt as Chief Business Officer, effective January 1, 2023.

Virax Biolabs announced today the distribution of HPV test kits with shipments anticipated in Q1 of 2023 to markets accepting the CE mark.

Arima Genomics, Inc., the leader in 3D genomics, today announced that it is launching into the world of single-cell analyses by enabling a team of researchers to map the 3D genome of the human brain, cell by cell.